Atezolizumab/bevacizumabLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2006卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57999-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：104 / 104

相关论文

共 50 条

[31] Acetazolamide/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 18 - 18
[32] Antineoplastics/bevacizumabLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1913 (1) : 73 - 73
[33] Antiglaucoma/acetazolamide/bevacizumabLack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 52 - 52
[34] Atezolizumab/irpagratinibLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 60 - 60
[35] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[36] BevacizumabLack of efficacy and small cerebral haemorrhage: 3 case reports
Reactions Weekly, 2023, 1985 (1) : 115 - 115
[37] Atezolizumab/Carboplatin/EtoposideLack of efficacy
Reactions Weekly, 2024, 2005 (1) : 129 - 129
[38] Atezolizumab/bevacizumab/lenvatinibLack of efficacy
Reactions Weekly, 2024, 2016 (1) : 72 - 72
[39] Atezolizumab/bevacizumab/pemetrexedLack of efficacy
Reactions Weekly, 2024, 2015 (1) : 73 - 73
[40] Atezolizumab/bevacizumabMyositis and lack of efficacy
Reactions Weekly, 2024, 1995 (1) : 33 - 33

← 1 2 3 4 5 →